Drug use in patients with headache in the post-covid period

Authors

  • Oxana GROSU Institutul de Neurology și Neurosurgery "Diomid Gherman", Chișinău, Republica Moldova

DOI:

https://doi.org/10.52692/1857-0011.2021.3-71.02

Keywords:

headache attributed to systemic viral infection, persistent post-COVID headache, drug abuse, medication overuse headache, long COVID, risk factors for chronification

Abstract

Drug use is a risk factor for the chronification of primary headaches and the development of secondary headaches. Forms of persistent post COVID headache have been reported, which may be due in part to the headache attributed to COVID 19 but also to drug use.
The aim of the study was to analyze post-COVID drug use in subjects with headaches and to compare with preinfection levels. Material and method: An online survey was done. Questionnaires were completed by subjects who had experienced COVID 19 infection and had a headache. The questionnaire was structured in 72 questions validated and approved by the institutional bioethics committee. Completion time - 20 min. The analysis of drug use was performed and the possible prediction factors were determined by simple multivariate regression.
Results: The study included 140 subjects with a mean age of 37.44 ± 10.18 years, 88.6% being women. They reported average drug use for the treatment of pain (days / month) before COVID 19 infection = 4.15 ± 4,041 (days /month) vs. during COVID 19 infection = 9.80 ± 7.742 (days / month) vs post COVID period = 7.7 ± 8.243 (days /month) (½ p <0.000, 1/3 p <0.026). Multivariate regression analysis allowed the prediction of factors that influence drug use. Model 1 - R2 = 0.471, p = 0.031, F = 2.13, df = 15; Predictor 1 = previous drug use before COVID: B = 0.641, β =0.408, t = 2.85, p = 0.017; Predictor 2 = post COVID headache: B = -2.33, β = -0.293, t = -2.09, p = 0.044; Predictor 3 =post COVID depression: B = - 4.00, β = -0.300, t = -2.09, p = 0.050.
Model 3 - R2 = 0.204, p = 0.004, F = 6.26, df = 2, Predictor 1 = drug use before COVID: B = 0.595, β = 0.379, t = 2.9, p = 0.005, Predictor 2 = vertigo post COVID: B = 2.183, β = 0.319, t = 2.462, p = 0.017
Conclusion: Drug use in the post-COVID period is associated with several factors but predictive value showed drug use before infection, the nature of post-COVID headache, depression, and vertigo in the post-COVID period.

Author Biography

Oxana GROSU, Institutul de Neurology și Neurosurgery "Diomid Gherman", Chișinău, Republica Moldova

dr. șt. med., cercet. șt.

References

Moro E, Priori A, Beghi E, et al. The international European Academy of Neurology survey on neurological symptoms in patients with COVID-19 infection. European journal of neurology : the official journal of the European Federation of Neurological Societies. 2020;27(9):1727-37. Epub 2020/06/20.

Lopez JT, Garcia-Azorin D, Planchuelo-Gomez A, et al. Phenotypic characterization of acute headache attributed to SARS-CoV-2: An ICHD-3 validation study on 106 hospitalized patients. Cephalalgia. 2020;40(13):1432-42. Epub 2020/11/05.

Uygun O, Ertas M, Ekizoglu E, et al. Headache characteristics in COVID-19 pandemic-a survey study. J Headache Pain. 2020;21(1):121. Epub 2020/10/15.

Martelletti P, Bentivegna E, Spuntarelli V, et al. Long-COVID Headache. SN Compr Clin Med. 2021:1-3. Epub 2021/05/27.

Liu J, de Luca RD, Mello Neto HO, et al. PostCOVID-19 Syndrome? New daily persistent headache in the aftermath of COVID-19. Arq Neuropsiquiatr. 2020;78(11):753-4. Epub 2020/12/18.

Curone M, Tullo V, Lovati C, et al. Prevalence and profile of obsessive-compulsive trait in patients with chronic migraine and medication overuse. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2014;35 Suppl 1:185-7. Epub 2014/05/29.

Dassieu L, Kabore JL, Choiniere M, et al. Understanding the link between substance use and chronic pain: A qualitative study among people who use illicit drugs in Montreal, Canada. Drug Alcohol Depend. 2019;202:50-

Epub 2019/07/14. 8. IHS. The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1-211. Epub 2018/01/26.

Stovner LJ, Nichols E, Steiner TJ, et al. Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology. 2018;17(11):954-76.

Al-Hashel JY, Abokalawa F, Alenzi M, et al. Coronavirus disease-19 and headache; impact on preexisting and characteristics of de novo: a cross-sectional study. J Headache Pain. 2021;22(1):97. Epub 2021/08/23.

Arca KN, Smith JH, Chiang CC, et al. COVID-19 and Headache Medicine: A Narrative Review of NonSteroidal Anti-Inflammatory Drug (NSAID) and Corticosteroid Use. Headache. 2020;60(8):1558-68. Epub 2020/07/11.

Fernandez-de-Las-Penas C, Gomez-Mayordomo V, Garcia-Azorin D, et al. Previous History of Migraine Is Associated With Fatigue, but Not Headache, as Long-Term Post-COVID Symptom After Severe Acute Respiratory SARS-CoV-2 Infection: A Case-Control Study. Front Hum Neurosci. 2021;15:678472. Epub 2021/07/24.

Moldovanu I. The prevalence of headache disorders in the Republic of Moldova : a population- based study. Cephalalgia. 2007;27:673.

Grosu O. Headaches in the context of the COVID-19 pandemic: preliminary results of a national survey. The Moldovan Medical Journal, 7th Congress of the Society of Neurologists Issue of the Republic of Moldova 2021;64.

Magdy R, Hussein M, Ragaie C, et al. Characteristics of headache attributed to COVID-19 infection and predictors of its frequency and intensity: A cross sectional study. Cephalalgia. 2020;40(13):1422-31. Epub 2020/11/05.

Rozen TD. Daily persistent headache after a viral illness during a worldwide pandemic may not be a new occurrence: Lessons from the 1890 Russian/Asiatic flu. Cephalalgia. 2020;40(13):1406-9. Epub 2020/11/05.

Caronna E, Alpuente A, Torres-Ferrus M, et al. Toward a better understanding of persistent headache after mild COVID-19: Three migraine-like yet distinct scenarios. Headache. 2021;61(8):1277-80. Epub 2021/08/08.

Dono F, Consoli S, Evangelista G, et al. New daily persistent headache after SARS-CoV-2 infection: a report of two cases. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2021;42(10):3965-8. Epub 2021/07/16.

Published

2021-11-17

Issue

Section

Research Article